Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HAEMONETICS CORPHAE · Entity 3953 | Director | July 24, 2026 | July 28, 2026 |
| Integer Holdings CorpITGR · Entity 4016 | Director | May 20, 2026 | May 22, 2026 |
| Medtronic plcMDT · Entity 2888 | EVP & Group Pres, Cardiac&Vasc | November 03, 2020 | November 05, 2020 |
| iRhythm Holdings, Inc.IRTC · Entity 1499 | Director · President and CEO | February 24, 2021 | February 27, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HAEMONETICS CORP
Report date July 24, 2026 · Filed July 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,932 |
Reported balance
After 2026-07-24 transaction · row 1
1 source rowRow 1 · 2026-07-24 · Grant · Acquired 2,538 · Balance 17,932 F1: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant. F2: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. |
Filing footnotes · ownership attribution and instrument terms
F1: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant.
F2: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
Integer Holdings Corp
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,322 |
Reported balance
After 2026-05-20 transaction · row 1
1 source rowRow 1 · 2026-05-20 · Grant · Acquired 1,967 · Balance 3,322 F1: Grant of restricted stock units ("RSUs") as of May 20, 2026. RSUs convert into common stock on a one-for-one basis, subject to vesting in approximately equal installments on August 20, 2026, November 20, 2026, February 20, 2027, and May 18, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units ("RSUs") as of May 20, 2026. RSUs convert into common stock on a one-for-one basis, subject to vesting in approximately equal installments on August 20, 2026, November 20, 2026, February 20, 2027, and May 18, 2027.
Medtronic plc
Report date November 03, 2020 · Filed November 05, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 190,390 |
Reported balance
After 2020-11-03 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-11-03 · Tax withholding · Disposed 393 · Balance 190,390 F1: This balance increased by 220 shares due to exempt transactions such as dividend reinvestment. |
| Ordinary SharesSEC Table I · non-derivative | IndirectBy Family Trust | 250 |
Reported balance
Holding disclosure · report date 2020-11-03 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 250 |
| Ordinary SharesSEC Table I · non-derivative | IndirectBy Spouse | 4,104 |
Reported balance
Holding disclosure · report date 2020-11-03 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 4,104 |
Filing footnotes · ownership attribution and instrument terms
F1: This balance increased by 220 shares due to exempt transactions such as dividend reinvestment.
iRhythm Holdings, Inc.
Report date February 24, 2021 · Filed February 27, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 33,247 |
Reported balance
After 2021-02-24 transaction · row 1
1 source rowRow 1 · 2021-02-24 · Grant · Acquired 33,247 · Balance 33,247 F1: The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on February 1, 2022 and each one-year anniversary thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on February 1, 2022 and each one-year anniversary thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 30, 2018 Filed Aug 1, 2018 19:44 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 16,465 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-024238 · form4.xml · nonDerivative · entry 1 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,089 F1 · kind: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share ("EPS") growth during the 36-month period ending on the last day of the Company's fiscal year 2021 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee. F2 · balance_after: This balance increased by 2155 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 18:53 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 65,103 | $0.00 Strike: $83.97 | $0.00 |
DisclosureSEC source: 0001127602-17-024704 · form4.xml · derivative · entry 5 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,103 Underlying: Ordinary Shares · 65,103 shares Expires 2027-07-31 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 18:53 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 1,191 | $0.00 Strike: $83.97 | $0.00 |
DisclosureSEC source: 0001127602-17-024704 · form4.xml · derivative · entry 4 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,191 Underlying: Ordinary Shares · 1,191 shares Expires 2027-07-31 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 18:53 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 16,276 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-024704 · form4.xml · nonDerivative · entry 1 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,469 F1 · kind: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share growth during the 36 month period ending on the last day of the Company's fiscal year 2020 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee. Read SEC document |
| July 28, 2017 Filed Aug 1, 2017 16:47 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 7,270 | $84.29 | $612,788.30 |
DisclosureSEC source: 0001127602-17-024472 · form4.xml · nonDerivative · entry 1 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,193 F1 · balance_after: This balance increased by 1,994 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.